Amersham Health launched analytical software designed to help practitioners better identify, measure, and manage costs associated with myocardial perfusion imaging studies on Jan. 8. MPOptions models economic factors affecting office-based and outpatient
Amersham Health launched analytical software designed to help practitioners better identify, measure, and manage costs associated with myocardial perfusion imaging studies on Jan. 8. MPOptions models economic factors affecting office-based and outpatient imaging centers and provides what-if scenarios to explore alternatives for delivering nuclear cardiology services efficiently and cost-effectively. The software calculates costs in several categories, including labor, capital equipment, facility, pharmaceutical, and supplies. MPOptions was developed with Amersham funding by physicians at Cardiovascular Consultants in St. Louis and Georgetown University in Washington, DC.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.